Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.
| YEAR | Impact Factor |
|---|---|
| 2024-25 | 3.5 |
| 2023 | 3.2 |
| 2022 | 3.6 |
| 2021 | 3.655 |
METABOLIC BRAIN DISEASE, 0885-7490, SPRINGER/PLENUM PUBLISHERS, Biochemistry, Genetics and Molecular Biology,Medicine,Neuroscience.